Use of Anxiety and Depression Drugs Linked to Increased PSA Testing

Elisa Becze, BA, ELS, Editor
Voice

Description

Patients who take anxiety or depression medication are more likely to obtain prostate-specific antigen (PSA) tests, according to study findings that researchers presented at the 2022 American Society of Clinical Oncology Genitourinary Cancers Symposium.

View Article @ voice.ons.org

ONS Voice Articles

ONS's member magazine articles.

View All Voice Articles